- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05473455
Value of Follicular Flushing. Randomised Controlled Trial
Does Addition of Follicular Flushing to the Initial Aspiration Lead to Higher Numbers of Oocytes Retrieved in Women Undergoing Oocyte Retrieval? A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is an ongoing debate regarding the effectiveness of follicular flushing during oocyte retrieval. Currently published studies and metanalyses suggest that follicular flushing does not improve live birth rate, clinical pregnancy rate or the number of oocytes retrieved. However, currently published studies may be confounded by the types of needle used, aspiration pressures, number of times flushing is repeated, etc. Additionally, follicular flushing should be examined in specific patient populations according to their response to ovarian stimulation.
In the current study, each woman will have one ovary (right or left) randomly assigned to be aspirated with or without the addition of follicular flushing. This study design ensures that clinical and demographic characteristics of the couple will not affect the outcomes evaluated. The primary endpoints will be the number of oocytes retrieved per ovary assigned to each group. Secondary outcomes will be the oocyte recovery rate (oocytes retrieved per follicle aspirated) oocyte maturation rate, fertilization rate, and embryo development per ovary assigned to each group.
The study population will include three subgroups according to observed ovarian response to ovarian stimulation (poor responders, normal responders, hyper responders). Assuming a minimum clinically significant difference in oocyte yield of 1 oocyte, a sample size of twenty patients per subgroup is required to yield 80% power.
Patients aged <43 years with the presence of at least one follicles >11mm in each ovary on the day of triggering final oocyte maturation will be eligible for inclusion in the study. 60 patients (20 in each of the aforementioned subgroup) will be recruited and just prior to oocyte retrieval their left and right ovaries will be randomly allocated into flushing or the no-flushing group. In both ovaries all follicles greater than 11mm will be punctured by the same 16G double lumen needle, using the same aspiration pressure. In the flushing group, flushing will be performed up to a maximum of five times or until a cumulus oocyte complex (COC) is retrieved.
In the control group all follicles greater than 11mm will be aspirated by the same double lumen needle and no flushing will be performed.
All COCs will be grouped according to the ovary they originated from by the embryologists and their development will be recorded until Day 3 following fertilization (Number of MII oocytes, number of fertilized oocytes, number good quality Day 3 embryos).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tryfon G Lainas, PhD
- Phone Number: +302107236333
- Email: tlainas@eugonia.com.gr
Study Contact Backup
- Name: George T Lainas, PhD
- Phone Number: +302107236333
- Email: ggslns@gmail.com
Study Locations
-
-
-
Athens, Greece, 11528
- Eugonia Unit of Assisted Reproduction
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Presence of both ovaries
- 18-43 years old
- At least one follicle >11mm present in each ovary on day of triggering final oocyte maturation.
Exclusion Criteria:
- Ovarian surgery
- Monofolicular development
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Follicular aspiration with addition of follicular flushing.
All follicles will be aspirated with the addition of follicular flushing if necessary (up to 5 times per follicle)
|
Follicular flushing if necessary up to 5 times using a double lumen needle for oocyte recovery
|
No Intervention: Follicular aspiration only.
All follicles will be aspirated and no flushing will be applied.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of oocytes retrieved
Time Frame: During oocyte collection (usually 10-30 minutes)
|
Number of oocytes retrieved per ovary randomised
|
During oocyte collection (usually 10-30 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oocyte recovery rate
Time Frame: During oocyte collection (usually 10-30 minutes)
|
Number of oocytes retrieved per follicle aspirated
|
During oocyte collection (usually 10-30 minutes)
|
Oocyte maturation rate
Time Frame: During oocyte denudation (usually 10-30 minutes)
|
Number of mature (metaphase-II) oocytes divided by the number of oocytes retrieved per ovary randomised
|
During oocyte denudation (usually 10-30 minutes)
|
Fertilization rate
Time Frame: During fertilisation check (usually 10 minutes)
|
Number of fertilised (2PN) oocytes divided by the number of matured oocytes retrieved per ovary randomised
|
During fertilisation check (usually 10 minutes)
|
Percentage of good quality embryos on day 2/3
Time Frame: During embryo evaluation (usually 10 minutes)
|
Number of good quality embryos divided by the number of fertilized oocytes per ovary randomised
|
During embryo evaluation (usually 10 minutes)
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- von Horn K, Depenbusch M, Schultze-Mosgau A, Griesinger G. Randomized, open trial comparing a modified double-lumen needle follicular flushing system with a single-lumen aspiration needle in IVF patients with poor ovarian response. Hum Reprod. 2017 Apr 1;32(4):832-835. doi: 10.1093/humrep/dex019.
- Franasiak JM. Follicular flushing: time to look elsewhere to improve in vitro fertilisation outcomes? BJOG. 2017 Jul;124(8):1197. doi: 10.1111/1471-0528.14628. No abstract available.
- Roque M, Sampaio M, Geber S. Follicular flushing during oocyte retrieval: a systematic review and meta-analysis. J Assist Reprod Genet. 2012 Nov;29(11):1249-54. doi: 10.1007/s10815-012-9869-9. Epub 2012 Oct 13.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Flushing RCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Experimental: Follicular aspiration with addition of follicular flushing.
-
Centrum Clinic IVF CenterCompletedDiminished Ovarian Reserve | Invitro Fertilization | OocyteTurkey
-
Weill Medical College of Cornell UniversityCompleted
-
Royan InstituteCompletedEmbryo Implantation | Follicular Fluid | Granulosa CellIran, Islamic Republic of
-
Hospital de Clinicas de Porto AlegreGuedes da Luz Médicos Associados Sociedade Simples LTDACompleted
-
University Hospital, Strasbourg, FranceCompletedInfertility, Female | Ovarian InsufficiencyFrance
-
Universitair Ziekenhuis BrusselCompletedInitiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola®) in the Late Follicular PhaseInfertility, FemaleBelgium
-
Instituto BernabeuTerminated
-
Cynosure, Inc.CompletedMelasmaUnited States
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerKorea, Republic of, United States, Australia, Hong Kong, Taiwan, Malaysia, Thailand, Argentina
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Belgium, Canada, Korea, Republic of, Portugal, France, United Kingdom, China, Germany, Japan, Mexico, Thailand, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Poland, Romania, Chile, Sw... and more